News

  • MIRASOL trial shows benefits for certain ovarian cancer patients

    AbbVie has announced the final analysis of the confirmatory Phase 3 MIRASOL trial evaluating the efficacy and safety of ELAHERE (mirvetuximab soravtansine-gynx) in women with folate receptor alpha (FRα)-positive platinum-resistant ovarian cancer (PROC) compared to chemotherapy. The results showed that at 30.5 months median follow-up, treatment with ELAHERE continued to show significant improvements in progression-free [...]

  • Cell atlas of the endometrium in women with PCOS may lead to better treatment

    Women with polycystic ovary syndrome (PCOS) find it harder to get pregnant, have more frequent miscarriages and have a higher risk of developing endometrial cancer. Now, researchers have shown that the uterine lining of these women differs in terms of both the composition of individual cells and gene expression. The results open the door to [...]

  • AI-powered partnership tackles recurring UTIs

    This Women’s Health Month, Ema, an AI-driven health technology leader, and MyUTI, a digital health pioneer in urinary and sexual health, are joining forces to combat a pervasive yet often minimised women's health issue: urinary tract infections (UTIs). This strategic partnership will integrate Ema's AI with MyUTI's evidence-backed resources, delivering personalized, accessible, and credible support [...]

  • Study confirms clinical decision impact of genomic diagnostic test in breast cancer

    A new study has revealed that the HER2DX diagnostics test impacts clinical decision making in early-stage HER2-positive breast cancer, leading to modifications in treatment plans. Developed by Reveal Genomics, HER2DX was shown to impact treatment decisions in a cohort of 297 patients with stage I-III HER2+ breast cancer across multiple hospitals in Spain. The primary [...]

  • Sigma Technology partners with Daya Ventures to close gender health gap

    Sigma Technology is partnering with Daya Ventures, a femtech venture studio, to close the US$1trn gender health gap.  Despite women making up half of the world’s population, they spend 25 per cent more of their lives in debilitating health than men. This disparity is due to a lack of clinical studies and insufficient investment in [...]

  • Listen now: The Femtech World Podcast — Cheryl Dowling, The IVF Warrior

    Cheryl Dowling, award-winning storyteller, advocate and the founder of The IVF Warrior, shares her own journey and thoughts on how to better support people experiencing infertility. CONTENT WARNING: In this episode we discuss infertility and IVF, so if that’s a difficult subject for you right now you might want to skip this one. Infertility is [...]

  • Significant cost disparities in UK fertility care, finds study

    A new study has found significant cost disparities and information challenges in UK fertility care, highlighting a need for immediate regulatory action. The study, carried out by Queen Mary's University London, explored the financial burden of fertility treatment add-ons, highlighting growing concerns over the reliability of information provided by clinics. According to the university, the [...]

  • Halle Berry and UCI researcher to advance menopause research and care

    Actress Halle Berry is teaming up with UCI researcher Pauline Maki to help advance menopause research and care. Hosting an event at the University Club of Chicago, Berry and Maki led talks on the impact that menopause has on the economy, access to care and the need for menopause research investment. Berry has been advocating [...]

  • Oxytocin system of breastfeeding affected in mothers with postnatal depression

    The oxytocin system – which helps release breast milk and strengthens the bond between mother and baby – may be affected during breastfeeding in mothers experiencing postnatal depression, a new study has found. The new research investigated the link between maternal mood and the oxytocin pathway during breastfeeding in mothers with and without symptoms of [...]

  • New insights into the origins of ovarian cancer

    Researchers have identified a novel trigger of a deadly form of ovarian cancer: a subset of progenitor cells that reside in fallopian tube supportive tissue, or stroma. The discovery of these high-risk cells could pave the way for better approaches to prevent and detect high-grade serous ovarian cancer (HGSOC), the most common form of ovarian [...]